Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1982-7-19
pubmed:abstractText
Pseudomonas cepacia mutants deficient in either 6-phosphogluconate (6PGA) dehydratase (Edd-) or 2-keto-3-deoxy-6-phosphogluconate (KDPG) aldolase (Eda-) failed to utilize glucose or gluconate despite the prominence of of 6-phosphogluconate dehydrogenase (6PGAD) ii this bacterium and the potential for utilizing the pentose shunt suggested by its growth on ribitol and xylose. The Eda- strains grew normally on glucuronic acid, indicating that in P. cepacia its degradation does not depend upon KDPG aldolase as it does in Escherichia coli. Both 6PGA dehydratase and KDPG aldolase were inducible enzymes, with 6PGA rather than gluconate the apparent inducer. Edd- as well as Eda- strains were sensitive to growth inhibition by glucose, gluconate, fructose, and related carbohydrates when these substrates were present in combination with alternate carbon sources such as citrate or phthalate, presumably as a consequence of accumulation and toxicity of 6PGA, KDPG, or both. Edd- mutants were somewhat less sensitive to such inhibition than were Eda- strains. Certain derivatives of the Edd- strains we examined were able to utilize gluconate despite their deficiency of 6PGA dehydratase. Such mutants formed higher levels of 6PGAD than did the wild type. It is likely that the elevated levels of 6PGAD in these strains prevents accumulation of toxic levels of 6PGA that would otherwise result from a block in he Entner-Doudoroff pathway. The results suggest that P. cepacia can mutate to grow slowly on gluconate utilizing only the pentose shunt.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-101528, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-13767412, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-139135, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-14367335, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-146701, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-163817, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-4154932, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-4382249, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-4402279, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-457605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-4627925, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-4945194, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-500557, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-533766, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-5337840, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-5337843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7076620-5354953
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0021-9193
pubmed:author
pubmed:issnType
Print
pubmed:volume
150
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1340-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Pseudomonas cepacia mutants blocked in the Entner-Doudoroff pathway.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.